T-cell blast crisis in chronic myelogenous leukemia: Immunophenotypic and molecular biologic findings

American Journal of Clinical Pathology

Volumn 107, Issue 2, 1997, Pages 168-176

  Dorfman, David M ^a   Longtine, Janina A ^a   Fox, Edward A ^a   Weinberg, David S ^a   Pinkus, Geraldine S ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Oncogene bcr abl; T lymphocyte; T cell receptor gene rearrangement

Indexed keywords

BCR ABL PROTEIN; T LYMPHOCYTE RECEPTOR;

ADULT; AGED; ARTICLE; BLAST CELL CRISIS; CASE REPORT; CHRONIC MYELOID LEUKEMIA; FEMALE; GENE DELETION; GENE REARRANGEMENT; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOPHENOTYPING; LYMPHADENOPATHY; LYMPHOBLAST; LYMPHOCYTOSIS; MALE; MOLECULAR BIOLOGY; ONCOGENE; PRIORITY JOURNAL; T LYMPHOCYTE; T LYMPHOCYTE RECEPTOR GENE;

EID: 0031033095     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajcp/107.2.168     Document Type: Article

References (49)

1. Kurzrock R, Gutterman JU, Talpaz M. The molecular genetics of Philadelphia chromosome-positive leukemias. N Engl J Med. 1988;319:990-998.
2. Kantarjian HM, Deisseroth A, Kurzrock R, Estrov Z, Talpaz M. Chronic myelogenous leukemia: a concise update. Blood, 1993;82:691-703.
3. Vardiman JW. Chronic myelogenous leukemia and the myeloproliferative disorders. In: Knowles DM, ed. Neoplastic Hematopathology. Baltimore, Md: Williams & Wilkins; 1992: 1405-1438.
4. Brunning RD, McKenna RW. Tumors of bone marrow. In: Atlas of Tumor Pathology. 3rd series, fascicle 9. Washington, DC: Armed Forces Institute of Pathology; 1994.
5. Hernandez P, Carnot J, Cruz C. Chronic myeloid leukaemia blast crisis with T-cell features. Br J Haematol. 1982;51:175-177.
6. Griffin JD, Tantravahi R, Canellos GP, et al. T-cell surface antigens in a patient with blast crisis of chronic myeloid leukemia. Blood. 1983;61:640-644.
7. Herrmann F, Komischke B, Kolecki P, et al. Ph′ (+) positive blast crisis of chronic myelogenous leukaemia exhibiting features characteristic of early T blasts. Scand J Haematol. 1984; 32:411-416.
8. Jacobs P, Greaves M. Ph′-positive T lymphoblastic transformation. Leuk Res. 1984;8:737-739.
9. Neame PB, Soamboonsrup P, Benger A, Brain MC. T cell surface antigens in blast crisis of CML. Blood. 1984;63:970-971.
10. Taniguchi C, Yamaguchi K, Yoshioka R, et al. Blast crisis of chronic myelogenous leukemia with tumor formation characterized by T-cell features: a case report. Jpn J Clin Oncol. 1984;14:123-127.
11. Allouche M, Bourinbaiar A, Goergoulias V, et al. T cell lineage involvement in lymphoid blast crisis of chronic myelogenous leukemia. Blood. 1985;66:1155-1161.
12. Cervantes F, Anegon I, Rozman C, et al. Early T-cell features in blast crisis of Ph′-positive chronic myelogenous leukaemia. Scand J Hematol. 1985;35:71-76.
13. Chan LC, Furley AJ, Ford AM, Yardumian DA, Greaves MF. Clonal rearrangement of the T cell receptor β gene and involvement of the breakpoint cluster region in blast crisis of CGL. Blood. 1986;67:533-536.
14. Falini BM, Tabilio A, Pelicci PG, et al. T-cell receptor β-chain gene rearrangement in a case of Ph′-positive chronic myelogenous leukaemia blast crisis. Br J Haematol. 1986;62; 776-779.
15. Fermand JP, Sigaux F, Tsapis A, et al. T cell-derived blast crisis in chronic myelogenous leukemia. Leukemia. 1987;1:210-212.
16. Kuriyama K, Gale RP, Tomonaga M, et al. CML-T1: a cell line derived from T-lymphocyte acute phase of chronic myelogenous leukemia. Blood. 1989;74:1381-1387.
17. Advani SH, Malhotra H, Kadam PR, et al. T-lymphoid blast crisis in chronic myelogenous leukemia. Am J Hematol. 1991; 36:86-92.
18. Sun T, Susin M, Koduru P, et al. Extramedullary blast crisis in chronic myelogenous leukemia: demonstration of T-cell lineage and Philadelphia chromosome in a paraspinal tumor. Cancer. 1991;68:605-610.
19. Maurer J, Thiel E. Rapid detection of chimeric bcr/abl mRNAs in acute lymphoblastic and chronic myelogenous leukemia by the polymerase chain reaction. Blut. 1990; 61:350-353.
20. Bakhshi A, Minowada J, Arnold A, et al. Lymphoid blast crises of chronic myelogenous leukemia represent stages in the development of B-cell precursors. N Engl J Med. 1983; 309:826-831.
21. Pinkus GS, O'Hara CJ, Said JW. Peripheral/post-thymic T-cell lymphomas: a spectrum of disease. Clinical, pathologic, and immunologic features of 78 cases. Cancer. 1990;65:971-998.
22. Pinkus GS, Pinkus JL, Goldstein NS, Shintaku IP, Said JW. BLA.36: a putative marker for B cell proliferations. Staining profile of 426 paraffin-embedded tissues. Appl Immunohistochem. 1995;3:23-31.
23. Longtine JA, Fox EA, Reynolds C, Sklar J. Molecular analysis of DNA rearrangements in leukemias and non-Hodgkin's lymphomas. In: Dracopoli NC, Haines JL, Korf BR, et al. Current Protocols in Human Genetics. New York, NY: John Wiley; 1994: 10.4.1-10.4.28.
24. Hata S, Clabby M, Devlin P, Spits H, De Vries JE, Krangel MS. Diversity and organization of human T cell receptor δ variable gene segments. J Exp Med. 1989;169:41-57.
25. Lefranc MP, Rabbitts TH. Two tandemly organized human genes encoding the T cell γ constant region sequence show multiple rearrangements in different T cell types. Nature. 1985;316:464-466.
26. Toyonahu B, Yoshikai Y, Vadaoz V, Chin B, Mak TW. Organization and sequences of the diversity joining and constant region genes of the human T cell receptor β chain. Proc Natl Acad Sci U S A. 1985;82:8624-8628.
27. Ritz J, Nadler LM, Bhan AK, Notis-McConarty J, Pesando JM, Schlossman RF. Expression of common acute lymphoblastic leukemia antigen (CALLA) by lymphomas of B-cell and T-cell lineage. Blood. 1981;58:648-652.
28. Sobol RE, Royston I, LeBien TW, et al. Adult acute lymphoblastic leukemia phenotypes defined by monoclonal antibodies. Blood. 1985;65:730-735.
29. Traweek ST. Immunophenotypic analysis of acute leukemia. Am J Clin Pathol. 1993;99:504-512.
30. Weiss LM, Bindl JM, Picozzi VJ, Link MP, Warnke RA. Lymphoblastic lymphoma: an immunophenotypic study of 26 cases with comparison to T cell acute lymphoblastic leukemia. Blood. 1986;67:474-478.
31. Carey JL, Hanson CA. Flow cytometric analysis of leukemia and lymphoma. In: Keren DF, Hanson CA, Hurtubise PE, eds. Flow Cytometry and Clinical Diagnosis. Chicago, Ill: American Society of Clinical Pathologists; 1994:197-308.
32. Stetler-Stevenson M, Medeiros LJ, Jaffe ES. Immunophenotypic methods and findings in the diagnosis of lymphoproliferative diseases. In: Jaffe ES, ed. Surgical Pathology of the Lymph Nodes and Related Organs. 2nd ed. Philadelphia, Pa: Saunders; 1995:22-57.
33. Riopel M, Dickman PS, Link MP, Perlman EJ. MIC2 analysis in pediatric lymphomas and leukemias. Hum Pathol. 1994; 25:396-399.
34. MIC2) neuroectodermal/Ewing's sarcoma antigen as an immunohistochemical marker. Appl Immunohistochem. 1994;2:231-240.
35. Link M, Warnke R, Finlay J, et al. A single monoclonal antibody identifies T-cell lineage of chidhood lymphoid malignancies. Blood. 1983;62:722-728.
36. Kurtzberg J, Waldmann TA, Davey MP, et al. CD7+, CD4-, CD8- acute leukemia: a syndrome of malignant pluripotent lymphohematopoietic cells. Blood. 1989;73:381-390.
37. Ben-Ezra J, Winberg CD, Wu A, Rappaport H. Leu-9 (CD7) positivity in acute leukemias: a marker of T cell lineage? Hematol Pathol 1987;1:147-156.
38. Knowles DM, Chadburn A, Inghirami G. Immunophenotypic markers useful in the diagnosis and classification of hematopoietic neoplasms. In: Knowles DM, ed. Neoplastic Hematopathology. Baltimore, Md: Williams & Wilkins; 1992:73-167.
39. Said JW, Stoll PN, Shintaku P, Bindl JM, Butmarc JR, Pinkus GS. Leu-22: a preferential marker for T-lymphocytes in paraffin sections. Am J Clin Pathol. 1989;91:542-549.
40. Hu ZB, Ma W, Uphoff CC, Metge K, Gignac SM, Drexler HG. Myeloperoxidase: expression and modulation in a large panel of human leukemia-lymphoma cell lines. Blood. 1993; 82:1599-1607.
41. Maurer J, Thiel E. Rapid detection of chimeric bcr/abl mRNAs in acute lymphoblastic and chronic myeloid leukemia by the polymerase chain reaction. Blut. 1990; 61:350-353.
42. Van Krieken JHJM, Elwood L, Andrade RE, Jaffe ES, Cossman J, Medeiros LJ. Rearrangement of the T-cell receptor delta chain gene in T-cell lymphomas with a mature phenotype. Am J Pathol. 1991;139:161-168.
43. Yumura-Yagi K, Hara J, Terada N, et al. Analysis of molecular events in leukemic cells arrested at an early stage of T-cell differentiation. Blood. 1989;74:2103-2111.
44. Inghirami G, Knowles DM. The immune system: structure and function. In: Knowles DM, ed. Neoplastic Hematopathology. Baltimore, Md: Williams & Wilkins; 1992:27-72.
45. Greisinger F, Greenberg JM, Kersey JH. T cell receptor gamma and delta rearrangements in hematologic malignancies. J Clin Invest. 1989;84:506-516.
46. Biondi A, Champagne E, Rossi V, et al. T-cell receptor delta gene rearrangement in childhood T-cell acute lymphoblastic leukemia. Blood. 1989;73:2133-2138.
47. Dyer MJS. T-cell receptor ∂/α rearrangements in lymphoid neoplasms. Blood. 1989;74:1073-1083.
48. β gene rearrangements in precursor T (lymphoblastic) neoplasms. Blood. 1986;68:134-139.
49. Weiss LM, Picker LJ, Grogan TM, Warnke RA, Sklar J. Absence of clonal beta and gamma T-cell receptor gene rearrangements in a subset of peripheral T-cell lymphomas. Am J Pathol. 1988;130:436-442.